
Kaos Capital Pushes for Board Changes at Capricor Therapeutics
Kaos Capital is actively pushing for significant board changes at Capricor Therapeutics, urging shareholders to support their proposals. The investment firm is seeking to influence the company's leadership and strategic direction.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)Sources
Coverage Timeline
Related Stories

Recent Corporate Earnings Releases Highlight Divergent Financial Performance
22m ago

Markets Brace for Nvidia Earnings and Key PCE Inflation Data
23m ago

OpenAI’s Head of Data Centers Chris Malone Departs the Company
25m ago
Enbridge Acquires Salt Creek Midstream Crude Gathering Assets for $600 Million
30m ago